A negative blood type is neither inherently good nor bad. Like every blood type, it carries a mix of minor statistical advantages and disadvantages that depend heavily on context. A negative means your red blood cells display the A antigen on the ABO system and lack the Rh(D) protein, making you part of roughly 6 percent of the population in the United States. The question of whether that combination is “good” touches on disease risk, pregnancy, transfusion logistics, and a few persistent myths that deserve a clear look at the evidence.
What the A and the Negative Actually Mean
Your blood type label has two parts. The letter (A, B, AB, or O) describes which sugar molecules sit on the surface of your red blood cells. The positive or negative refers to the Rh(D) protein, a completely separate marker. Being A negative means you have the A surface antigen but not the Rh(D) protein. These two systems are independent of each other and influence your health in different ways, so lumping them into a single verdict of “good” or “bad” doesn’t make much sense. It’s more useful to look at what each part means on its own.
Heart Disease and Blood Clots
One of the most consistent findings in blood-type research is that people with non-O blood groups, including type A, face a modestly higher risk of cardiovascular problems compared to those with type O. A large analysis following participants across two long-running studies found that people with blood group A had an adjusted hazard ratio for coronary heart disease of about 1.08 compared to group O, meaning roughly an 8 percent higher relative risk. Group AB showed a somewhat larger bump, around 20 percent higher relative risk.1PubMed Central. ABO Blood Group and Risk of Coronary Heart Disease in Two Prospective Cohort Studies These are not dramatic numbers. They sit in the same range as many everyday lifestyle factors, and they don’t override the influence of diet, exercise, smoking, or blood pressure.
Blood clotting is where the gap widens a bit more. Non-O blood types tend to have higher levels of von Willebrand factor and factor VIII, two proteins involved in clot formation. In one study of patients who also carried an inherited clotting tendency, having a non-O blood group roughly doubled the odds of venous thrombosis on its own, and the combination of non-O blood type with an inherited thrombophilia pushed the odds ratio above 7.2PubMed Central. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia For most people without an underlying clotting disorder, the extra risk from blood type alone is small. But if you already know you carry a genetic clotting condition, being type A (or any non-O type) is worth mentioning to your doctor.
Cancer Associations
Gastric cancer has one of the most studied links to blood type. A large genetic study combined with a meta-analysis of 40 studies found that blood group A was associated with about a 19 percent increase in the odds of gastric cancer compared to group O.3PubMed Central. Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review A separate study examining prognosis among gastric cancer patients found that group A carried a worse outlook once the disease was already present.4PubMed. Prognostic value of ABO blood group in patients with gastric cancer
Pancreatic cancer follows a similar pattern. In a prospective study of over 100,000 participants, those with blood group A had an adjusted hazard ratio of about 1.32 for developing pancreatic cancer compared to type O, and an estimated 17 percent of pancreatic cancer cases overall were attributable to having any non-O blood group.5PubMed Central. ABO Blood Group and the Risk of Pancreatic Cancer A Japanese study confirmed the trend, finding that each additional non-O allele incrementally raised pancreatic cancer risk.6PubMed Central. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
These numbers sound alarming in isolation, but context matters. Gastric and pancreatic cancers are relatively uncommon to begin with. A 20-to-30 percent increase in the relative risk of an uncommon disease still leaves the absolute risk quite low for any individual. Factors like smoking, Helicobacter pylori infection, alcohol use, and family history have far more influence on whether someone actually develops these cancers than their ABO type does.
Infections and Immunity
Blood type’s role in infectious disease is one of the more fascinating corners of the research, though the effects vary wildly by pathogen.
Malaria is the clearest case. Blood group O is associated with a roughly 66 percent reduction in the odds of developing severe falciparum malaria compared to non-O groups, an effect linked to how the malaria parasite causes infected red blood cells to clump together in structures called rosettes.7PubMed Central. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting Non-O blood groups, including A, allow larger and more stable rosettes to form, which worsen the disease.8PubMed Central. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention Genotype-level analysis has confirmed that the specific non-O alleles matter, with different combinations showing different degrees of risk for rosetting and severe outcomes.9PLOS Genetics. Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria If you live in or travel to a malaria-endemic region, being type A is a marginal disadvantage compared to type O. For people living in temperate climates where malaria is absent, this particular risk is irrelevant.
Norovirus, the notorious stomach bug, offers a twist. The prototype Norwalk virus specifically recognizes A-type and H-type sugars on cell surfaces, meaning people with blood group A and blood group O (which expresses the H antigen) can be susceptible to certain strains.10PubMed Central. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus Interestingly, the virus does not bind to B-type sugars, which gives people with blood group B some degree of natural resistance to those particular strains.11PubMed. Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids Different norovirus strains bind different sugar types, though, so no single blood group provides blanket protection across all norovirus variants.12PubMed Central. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding
COVID-19 generated enormous public interest in blood type associations early in the pandemic. Some early studies suggested that type O was protective against infection and death, while type A was associated with higher risk. One review cited odds ratios of 1.21 for infection in type A and 0.67 for type O.13PubMed Central. Relationship between blood type and outcomes following COVID-19 infection However, larger and more controlled studies that followed patients across multiple COVID variant waves found no meaningful difference in severe disease outcomes between blood types, with severe illness rates ranging between 8.6 and 8.9 percent across all four ABO groups.14PubMed Central. Association between ABO blood type and coronavirus disease 2019 severe outcomes across dominant variant strains Another study looking at hospitalized patients found no significant differences in mortality, ICU admission, or other outcomes by blood type.15PubMed Central. The association of ABO blood type with the risk and severity of COVID-19 infection The early signals were likely confounded by population differences and small sample sizes. As evidence accumulated, the story faded to essentially no effect.
Dementia and Cognitive Decline
You may have seen headlines linking blood type to Alzheimer’s risk. A large Scandinavian record-linkage study looked at this directly and found no association between ABO blood group and risk of Alzheimer’s disease, vascular dementia, or unspecified dementia. The only finding of note was a very slight decrease in overall dementia risk for blood group A among donors over 70, which the authors described as marginal.16PubMed Central. ABO Blood Group and Dementia Risk – A Scandinavian Record-Linkage Study If anything, being type A showed a barely detectable protective signal in that one study, though it would be unwise to read much into a single borderline result. The honest summary is that blood type does not appear to play a meaningful role in dementia risk.
The Rh-Negative Factor in Pregnancy
For women with A negative blood, the “negative” part becomes clinically important during pregnancy. If an Rh-negative mother carries an Rh-positive baby (which happens when the father is Rh-positive), small amounts of fetal blood can cross the placenta and trigger the mother’s immune system to produce antibodies against the Rh(D) protein. This process, called Rh alloimmunization, can cause problems in subsequent pregnancies if those antibodies attack the red blood cells of another Rh-positive fetus.
A study comparing Rh-negative pregnancies to Rh-positive controls found that Rh-negative mothers had higher rates of postpartum blood loss, neonatal jaundice (about 39 percent vs. 23 percent), low birth weight, and NICU admission.17PubMed Central. Analysis of pregnancy and neonatal outcomes in 100 pregnant women with Rh-negative blood type These numbers represent what happens even with modern monitoring. But the good news is that the most serious consequences of Rh incompatibility have been largely neutralized by a routine injection of anti-D immunoglobulin given around 28 to 30 weeks of pregnancy. This treatment reduces the rate of alloimmunization from about 1 to 2 percent down to approximately 0.2 percent by clearing fetal red blood cells from the mother’s circulation before her immune system can mount a lasting response.18PubMed Central. The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation
Rh-negative women do need to be aware of this and make sure their pregnancy care includes the appropriate timing of anti-D shots, particularly after any event that might mix fetal and maternal blood, such as miscarriage, amniocentesis, or abdominal trauma. With proper management, the vast majority of Rh-negative pregnancies proceed safely. It’s an extra step, not a crisis.
Blood Supply and Donation
Here is where A negative actually shines. Because only about 6 percent of the population has this type, the supply of A negative blood can be tight. Blood banks constantly need donations from people with less common types. If you’re A negative, your red blood cells can be given to anyone who is either A negative or A positive in an emergency, and your platelets and plasma are especially useful in certain clinical situations. Rh-negative blood in general is in high demand for transfusing Rh-negative patients, because giving Rh-positive blood to an Rh-negative recipient can trigger the same kind of antibody response that causes problems in pregnancy.
O negative gets most of the attention as the “universal donor” type, but A negative donors fill an important gap. Hospitals can’t run on O negative alone, and having an adequate supply of A negative on the shelf means they can save the rarer O negative units for true emergencies where the patient’s type is unknown. If you’re looking for a practical upside to your blood type, regular donation is it.
Why Rh-Negative Blood Types Exist at All
Given that Rh incompatibility can harm pregnancies, you might wonder why the Rh-negative trait persists at all. The frequency of the RHD gene deletion responsible for Rh-negative status is surprisingly high in European populations, around 0.43 in one study. Researchers found no clear evidence that positive natural selection drove the deletion to that frequency. Instead, the initial rise may have been the result of genetic drift or a founder effect, essentially an accident of population history. Intriguingly, once the deletion reaches an intermediate frequency, selection against it becomes very weak, so random chance alone can keep it hovering near its current level.19PubMed Central. Evolutionary genetics of the human Rh blood group system In other words, Rh-negative blood may not be there because it provides an advantage. It may persist simply because, at common frequencies, evolution can’t easily push it out.
The Blood Type Diet Myth
One of the most enduring popular claims about blood types is that you should eat differently based on your type. The “Blood Type Diet” book, published in the late 1990s, recommends that type A individuals follow a largely vegetarian diet, avoid red meat, and eat plenty of soy and grains. Millions of copies have been sold. The evidence? A systematic review found zero studies validating the health benefits of eating according to blood type.20PubMed. Blood type diets lack supporting evidence: a systematic review
A follow-up study went further. Researchers tracked young adults’ adherence to the various blood-type diets and measured their cardiometabolic markers. They found that following certain patterns recommended in the book (like the “type A diet”) was indeed associated with better health markers, but the benefits were the same regardless of the person’s actual blood type. In other words, a type A person eating the “type A diet” did no better than a type O person eating the same diet. The improvements came from the diet’s overall composition, not from any match to blood type.21PLoS ONE. ABO Genotype, ‘Blood-Type’ Diet and Cardiometabolic Risk Factors If you enjoy eating the foods recommended for type A, go ahead. Just know that the “match” to your blood type is doing nothing special.
Putting It in Perspective
The honest answer to “is A negative a good blood type?” is that it’s a perfectly normal one with a specific set of minor trade-offs. Compared to type O, you face slightly elevated statistical risks for coronary disease, blood clots, and certain cancers, but these effects are modest and heavily outweighed by lifestyle factors you can control. Compared to type B, you may be more susceptible to some norovirus strains but potentially at a slight advantage in other infections. The Rh-negative component adds a genuine practical consideration during pregnancy, but modern immunoprophylaxis has made Rh disease largely preventable. And on the positive side, your blood is relatively uncommon and highly valued by blood banks.
The broader lesson from blood-type research is that ABO and Rh status influence biology in real but small ways. They’re one thread in a massive tapestry of genetics, environment, and behavior. No blood type is a health sentence, and no blood type is a golden ticket. The research is worth knowing about, especially the pregnancy and clotting connections, but it shouldn’t cause anyone to lose sleep over a label on their donor card.